Clinical analyte determination by infrared spectroscopy
First Claim
1. An in-vitro method for determining the concentration of one or more clinical analytes comprising the steps of:
- (a) obtaining a volume of a fluid sample comprising interstitial fluid;
(b) contacting a portion of said sample on a plane of an optically clear first window;
(c) placing a second optically clear window in contact with the first window to thereby sandwich the sample between the windows;
(d) shining a known wavelength of light from the mid-infrared spectrum for an uncontrolled path length through said windows and said sample in a path perpendicular to said plane;
(e) measuring a spectrophotometric property of said light; and
(f) performing a quantitative mathematical analysis of said spectrophotometric property to determine the concentration of at least one analyte, wherein the fluid sample is obtained by creating a micropore on the surface of the skin of a patient, wherein said micropore at least partially fills with interstitial fluid and pressing said first window against the micropore to collect a volume of said interstitial fluid.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention comprises methods for minimally invasive and noninvasive analyte determination using infrared spectroscopy. A minimally invasive in vitro method comprises obtaining a volume of a fluid sample. A minimally invasive manner of obtaining the sample includes using a laser to form a micropore on a user'"'"'s skin. The sample is placed on a plane of an optically clear window, such as by pressing the window against the micropore. Infrared light is directed through the window and the sample at an angle such that the light path is approximately vertical. The resulting spectrum is measured and subjected to multivariate analysis to determine the presence of at least one analyte. A noninvasive in vivo method comprises obtaining a spectral measurement of a sample in conjunction with the arterial pulse measurement. A difference spectrum is determined by subtracting the arterial pulse trough measurement from the peak measurement. The difference spectrum is normalized by dividing by the area of the absolute value of the derivative spectrum. The presence of at least one analyte is determined by applying multivariate analysis to the normalized spectrum.
-
Citations
16 Claims
-
1. An in-vitro method for determining the concentration of one or more clinical analytes comprising the steps of:
-
(a) obtaining a volume of a fluid sample comprising interstitial fluid;
(b) contacting a portion of said sample on a plane of an optically clear first window;
(c) placing a second optically clear window in contact with the first window to thereby sandwich the sample between the windows;
(d) shining a known wavelength of light from the mid-infrared spectrum for an uncontrolled path length through said windows and said sample in a path perpendicular to said plane;
(e) measuring a spectrophotometric property of said light; and
(f) performing a quantitative mathematical analysis of said spectrophotometric property to determine the concentration of at least one analyte, wherein the fluid sample is obtained by creating a micropore on the surface of the skin of a patient, wherein said micropore at least partially fills with interstitial fluid and pressing said first window against the micropore to collect a volume of said interstitial fluid. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
(a) normalizing said spectrum; and
(b) performing a multivariate analysis.
-
-
10. An in vitro method of clinical analyte determination as recited in claim 9, wherein the step of normalizing said spectrum further comprises dividing said spectrum by the area of the absolute value of the derivative spectrum.
-
11. The method of claim 1, wherein the step of performing a mathematical analysis further comprises determining the presence of glucose.
-
12. The method of claim 1, wherein the fluid sample comprises whole blood and the step of performing a mathematical analysis further comprises determining the presence of hemoglobin.
-
13. The method of claim 1, wherein the step of performing a mathematical analysis further comprising determining the presence of urea.
-
14. The method of claim 1, wherein the step of performing a mathematical analysis further comprising determining the presence of cholesterol.
-
15. The method of claim 1, wherein the step of performing a mathematical analysis further comprising determining the presence of any combination of glucose, urea and cholesterol.
-
16. An apparatus for clinical analyte determination, comprising:
-
means for obtaining a volume of a fluid sample, wherein at least a portion of said sample is disposed on a plane of an optically clear window;
means for shining a known wavelength of light from the mid-infrared spectrum through said window and said sample in a path perpendicular to said plane;
means for measuring a spectrum produced by the transmittance of said light; and
means for performing a mathematical analysis of said spectrum to determine the presence of an analyte, wherein the means for obtaining a volume of a fluid sample comprise means for creating a micropore on the surface of the skin of a patient that will at least partially fill with interstitial fluid and a first window for pressing against the micropore to collect a volume of said interstitial fluid.
-
Specification